+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidepressant"

Dysthymia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Dysthymia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Bulimia Nervosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Bulimia Nervosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Post-Traumatic Stress Disorder (PTSD) Pipeline Analysis Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2023
  • 117 Pages
  • Global
From
Major Depressive Disorder: 68-Market Analysis and Sales Forecast - Update - Product Thumbnail Image

Major Depressive Disorder: 68-Market Analysis and Sales Forecast - Update

  • Report
  • March 2025
  • 18 Pages
  • Global
From
Major Depressive Disorder: Eight-Market Drug Forecast and Market Analysis - Update (2025) - Product Thumbnail Image

Major Depressive Disorder: Eight-Market Drug Forecast and Market Analysis - Update (2025)

  • Report
  • March 2025
  • 118 Pages
  • Global
From
Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 292 Pages
  • Global
From
Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • May 2025
  • 250 Pages
  • Global
From
Anxiety Disorders and Depression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Anxiety Disorders and Depression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • April 2025
  • 205 Pages
  • Global
From
Sertraline Hcl Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Sertraline Hcl Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Treatment-Resistant Depression Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Distribution Channel - Product Thumbnail Image

Treatment-Resistant Depression Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Distribution Channel

  • Report
  • August 2026
  • 160 Pages
From
Post-Traumatic Stress Disorder Therapeutics: Market Share, and Growth Analysis by Product Type (Medications, Psychotherapy, Alternative Therapies), Application, End User, Technology - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics: Market Share, and Growth Analysis by Product Type (Medications, Psychotherapy, Alternative Therapies), Application, End User, Technology

  • Report
  • August 2025
  • 150 Pages
  • Global
From
Psychedelic Drugs: Market Share, and Growth Analysis by Product Type (LSD, Psilocybin, MDMA, Ketamine), Application, End User, Technology - Product Thumbnail Image

Psychedelic Drugs: Market Share, and Growth Analysis by Product Type (LSD, Psilocybin, MDMA, Ketamine), Application, End User, Technology

  • Report
  • August 2025
  • 150 Pages
  • Global
From
Aripiprazole Drug Market in China - Product Thumbnail Image

Aripiprazole Drug Market in China

  • Report
  • March 2026
  • 372 Pages
  • China
From
Antipsychotic Drug Market in Germany - Product Thumbnail Image

Antipsychotic Drug Market in Germany

  • Report
  • December 2025
  • 150 Pages
  • Germany
From
Antipsychotic Drug Market in India - Product Thumbnail Image

Antipsychotic Drug Market in India

  • Report
  • November 2025
  • 150 Pages
  • India
From
Antipsychotic Drug Market in Japan - Product Thumbnail Image

Antipsychotic Drug Market in Japan

  • Report
  • November 2025
  • 150 Pages
  • Japan
From
Antipsychotic Drug Market in China - Product Thumbnail Image

Antipsychotic Drug Market in China

  • Report
  • November 2025
  • 150 Pages
  • China
From
Psychotropic Drug Market in Germany - Product Thumbnail Image

Psychotropic Drug Market in Germany

  • Report
  • October 2025
  • 150 Pages
  • Germany
From
Loading Indicator

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more